SEYMOUR TAMARA A 4
4 · KEMPHARM, INC · Filed Jun 30, 2022
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
SEYMOUR TAMARA A
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-28+15,000→ 15,000 totalExercise: $4.52Exp: 2032-06-27→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 28, 2022.
- [F2]This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's seventh amended and restated non-employee director compensation policy.
- [F3]One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.